Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions - a case report and a literature review.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024

Same author

Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.

Folia biologica·2023

Same author

Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features.

Folia biologica·2023

Same author

Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.

Journal of nephrology·2020

Same author

Thrombotic microangiopathy and pregnancy.

Ceska gynekologie·2020

Same author

New Developments in Understanding the Histological Structure of Human Ear Cartilage.

Folia biologica·2020

Same journal

EBV-associated plasmacytic variant of Castleman disease: more than a decade-long diagnostic odyssey - a case report.

Ceskoslovenska patologie·2026

Same journal

Castleman-Like Lymphadenopathy in a Patient with Mixed Connective Tissue Disease: A Case Report and Review of the Literature.

Ceskoslovenska patologie·2026

Same journal

Targeted gene expression profiling as a tool for diagnostic cell-of-origin determination and prognostic stratification in diffuse large B-cell lymphoma.

Ceskoslovenska patologie·2026

Same journal

The advantages and limitations of the new FIGO 2023 staging system for endometrial carcinoma from the perspective of the clinician and pathologist.

Ceskoslovenska patologie·2026

Same journal

Castleman disease - one name, many faces.

Ceskoslovenska patologie·2026

Same journal

Testing Claudin 18.2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma: Current Status and Near‑Future Outlook.

Ceskoslovenska patologie·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

[Systemic amyloidoses in renal biopsy samples].

L Bauerová¹, E Honsová, R Rysavá

¹Ustav patologie, 1. LF UK a VFN, Praha.

Ceskoslovenska Patologie

|September 22, 2009

Summary

This summary is machine-generated.

Kidney amyloidosis, often AL or AA type, requires precise classification for effective treatment. This study analyzed renal biopsies, finding immunofluorescence crucial for accurate diagnosis and patient management.

More Related Videos

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Related Experiment Videos

Last Updated: Jun 20, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry

Published on: March 7, 2019

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Area of Science:

Nephrology
Pathology
Immunology

Context:

Kidney amyloidosis is a significant complication of systemic AL, AA, and hereditary amyloidoses.
Accurate differentiation of amyloid types is critical due to distinct therapeutic strategies.
Renal biopsy is a key diagnostic tool for evaluating amyloid deposition in the kidneys.

Purpose:

To retrospectively analyze renal biopsy samples over five years to determine the prevalence and types of amyloidosis.
To evaluate the utility of immunofluorescence and immunohistochemical staining in classifying renal amyloidosis.
To assess the diagnostic accuracy and clinical suspicion of amyloidosis by nephrologists.

Summary:

A five-year retrospective study of 996 renal biopsies identified amyloidosis in 6.2% of cases.
AL amyloidosis accounted for 53.2% and AA amyloidosis for 40.3%, with four cases unclassified.
Immunofluorescence and immunohistochemistry were employed for classification, with immunofluorescence noted as highly useful in daily practice.

Impact:

Establishes the prevalence of AL and AA amyloidosis in renal biopsies within the studied cohort.
Highlights the diagnostic challenges and the importance of precise amyloid typing for guiding patient therapy.
Emphasizes the clinical utility of immunofluorescence in the routine classification of renal amyloidosis, aiding nephrologists in diagnosis and treatment planning.